BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 24378942)

  • 1. Impact of antiretroviral therapy on opportunistic infections of HIV-infected children in the therapeutic research, education and AIDS training asia pediatric HIV observational database.
    Prasitsuebsai W; Kariminia A; Puthanakit T; Lumbiganon P; Hansudewechakul R; Siew Moy F; Law M; Kumarasamy N; Razali K; Sirisanthana V; Sohn AH; Chokephaibulkit K
    Pediatr Infect Dis J; 2014 Jul; 33(7):747-52. PubMed ID: 24378942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Ylitalo N; Brogly S; Hughes MD; Nachman S; Dankner W; Van Dyke R; Seage GR;
    Arch Pediatr Adolesc Med; 2006 Aug; 160(8):778-87. PubMed ID: 16894075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and predictors of HIV related opportunistic infections after initiation of highly active antiretroviral therapy at Ayder Referral Hospital, Mekelle, Ethiopia: A retrospective single centered cohort study.
    Arefaine ZG; Abebe S; Bekele E; Adem A; Adama Y; H Brockmeyer N; Coenenberg J; Potthoff A; Gebremeskel TG
    PLoS One; 2020; 15(4):e0229757. PubMed ID: 32310961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short- and Long-term Risks of Highly Active Antiretroviral Treatment with Incident Opportunistic Infections among People Living with HIV/AIDS.
    Yen YF; Chen M; Jen IA; Chuang PH; Lee CY; Lin SI; Chen YA
    Sci Rep; 2019 Mar; 9(1):3476. PubMed ID: 30837537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and Prevalence of Opportunistic and Other Infections and the Impact of Antiretroviral Therapy Among HIV-infected Children in Low- and Middle-income Countries: A Systematic Review and Meta-analysis.
    B-Lajoie MR; Drouin O; Bartlett G; Nguyen Q; Low A; Gavriilidis G; Easterbrook P; Muhe L
    Clin Infect Dis; 2016 Jun; 62(12):1586-1594. PubMed ID: 27001796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy.
    Dankner WM; Lindsey JC; Levin MJ;
    Pediatr Infect Dis J; 2001 Jan; 20(1):40-8. PubMed ID: 11176565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morbidity after antiretroviral therapy initiation in HIV-1-infected children in West Africa: temporal trends and relation to CD4 count.
    De Beaudrap P; Boullé C; Lewden C; Gabillard D; Nacro B; Diagbouga S; Fassinou P; Hien H; Laurent C; Msellati P;
    Pediatr Infect Dis J; 2013 Apr; 32(4):354-60. PubMed ID: 23099424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of opportunistic and other infections in HIV-infected children in the HAART era.
    Gona P; Van Dyke RB; Williams PL; Dankner WM; Chernoff MC; Nachman SA; Seage GR
    JAMA; 2006 Jul; 296(3):292-300. PubMed ID: 16849662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
    Mofenson LM; Brady MT; Danner SP; Dominguez KL; Hazra R; Handelsman E; Havens P; Nesheim S; Read JS; Serchuck L; Van Dyke R; ; ; ; ;
    MMWR Recomm Rep; 2009 Sep; 58(RR-11):1-166. PubMed ID: 19730409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of highly active antiretroviral treatment on TB incidence among HIV infected children and their clinical profile, retrospective cohort study, South West Ethiopia.
    Tiruneh F; Deyas Y
    Sci Rep; 2020 Dec; 10(1):21468. PubMed ID: 33293656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of opportunistic illness before and after initiation of highly active antiretroviral therapy in children.
    Nesheim SR; Hardnett F; Wheeling JT; Siberry GK; Paul ME; Emmanuel P; Bohannon B; Dominguez K;
    Pediatr Infect Dis J; 2013 Oct; 32(10):1089-95. PubMed ID: 24067552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of common opportunistic infections among HIV-infected children on ART at Debre Markos referral hospital, Northwest Ethiopia: a retrospective cohort study.
    Melkamu MW; Gebeyehu MT; Afenigus AD; Hibstie YT; Temesgen B; Petrucka P; Alebel A
    BMC Infect Dis; 2020 Jan; 20(1):50. PubMed ID: 31948393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era.
    Brady MT; Oleske JM; Williams PL; Elgie C; Mofenson LM; Dankner WM; Van Dyke RB;
    J Acquir Immune Defic Syndr; 2010 Jan; 53(1):86-94. PubMed ID: 20035164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and associated factors of pulmonary tuberculosis in HIV-infected children after highly active antiretroviral therapy (HAART) in China: a retrospective study.
    Mu W; Zhao Y; Sun X; Ma Y; Yu L; Liu X; Zhao D; Dou Z; Fang H; Zhang F
    AIDS Care; 2014; 26(9):1127-35. PubMed ID: 24512621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and distribution patterns of opportunistic infections associated with HIV/AIDS in Uganda.
    Rubaihayo J; Tumwesigye NM; Konde-Lule J; Wamani H; Nakku-Joloba E; Makumbi F
    BMC Res Notes; 2016 Dec; 9(1):501. PubMed ID: 27927247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso.
    Dembélé M; Saleri N; Carvalho AC; Saouadogo T; Hien AD; Zabsonre I; Koala ST; Simporé J; Matteelli A
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):318-23. PubMed ID: 20132623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opportunistic infections in relation to antiretroviral status among AIDS patients from south India.
    Srirangaraj S; Venkatesha D
    Indian J Med Microbiol; 2011; 29(4):395-400. PubMed ID: 22120801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy.
    Hung CC; Chen MY; Hsiao CF; Hsieh SM; Sheng WH; Chang SC
    AIDS; 2003 Dec; 17(18):2615-22. PubMed ID: 14685055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.